See risk earlier
483Radar scores FDA inspection risk from structured citation history, site exposure, cohort behavior, time-based inspection pressure, and reliability thresholds so teams can act before risk becomes visible internally.
483Radar
See FDA inspection risk earlier.
483Radar turns FDA Form 483 citation trends, inspection pressure, and warning letter signals into a scored facility view, dated executive brief, and one clear first action for pharma and medical device quality teams.
BlindSpot CFR signal familiesObservation risk outlookInspection pressure forecastsReliability-scored executive brief
This is the risk-intelligence side of LeanStorming: helping companies see weak signals earlier, prioritize preparation, and focus leadership attention before pressure becomes expensive.
Benefits
A sharper way to identify regulatory risk before it becomes exposure.
483Radar is positioned as deterministic FDA risk modeling, not keyword search or a generic AI summary.
Create an executive action path
The product turns Form 483 patterns, citation signals, and inspection data into dated briefs for QA, regulatory, operations, finance, and leadership teams.
Focus limited review capacity
Teams can narrow external FDA pressure into the CFR domain, timing window, control gap, and sponsor-level ask that matter first.
Use Cases
Use 483Radar when inspection pressure needs a concrete decision path.
The live product page describes a single-facility beta pilot, weekly FDA dataset refresh, scored modules, and a shareable executive brief.
Single-facility beta review
Review one facility with a guided MVP workflow and an executive brief before the next inspection cycle tightens.
FDA inspection readiness
Identify which CFR themes and inspection-pressure signals are building around facilities like yours.
Cross-functional risk alignment
Give Quality, Operations, Finance, and executive leadership a shared view of the first risk worth action.